BioReference Laboratories, Inc.'s (BRLI) second-quarter net income after taxes rose to $11.34 million, or $0.41 a share, from $9.31 million, or $0.33 a share, as adjusted for Topic 954, last year. On average, 5 analysts polled by Thomson Reuters expected earnings per share of $0.41 for the quarter. Analysts' estimates typically exclude one-time items.
The company said it recorded quarterly revenues of $176.45 million, the highest recorded revenues in a quarter in corporate history, up 17% over the $151.44 million, as adjusted for Topic 954, recorded in the second quarter of fiscal 2012. Analysts estimated revenues of $176.04 million for the quarter.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.